Virtual Library

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    International Society of Nurses in Cancer Care (ISNCC) & BMS Foundation Collaborative Workshop (Sign up Required) (ID 507)

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 15
    • Moderators:
    • Coordinates: 12/04/2016, 08:00 - 12:00, Schubert 5
  • +

    JCES01 - Joint IASLC - Chinese Society for Clinical Oncology - Chinese Alliance Against Lung Cancer Session (ID 413)

    • Type: Joint Chinese / English Session
    • Track:
    • Presentations: 28
  • +

    WS03 - IASLC Meets ESTI: Imaging in Lung Cancer Staging and Diagnosis (ID 361)

    • Type: Workshop
    • Track: Radiology/Staging/Screening
    • Presentations: 4
  • +

    WS04 - Mesothelioma Workshop (Ticketed Session) (ID 416)

    • Type: Workshop
    • Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
    • Presentations: 6
    • Moderators:
    • Coordinates: 12/04/2016, 08:00 - 11:00, Stolz 2
  • +

    YI01a - Clinical Trials & Scientific Mentoring (ID 414)

    • Type: Young Investigator Session
    • Track: WCLC 2016
    • Presentations: 5
  • +

    YI01b - Scientific Mentoring (ID 415)

    • Type: Young Investigator Session
    • Track:
    • Presentations: 5
  • +

    PR01 - Press Conference (ID 495)

    • Type: Press Conference
    • Track:
    • Presentations: 6
  • +

    ISS01 - Industry Supported Symposium: Current and Emerging Treatments for Patients with ALK+ NSCLC – ARIAD Pharmaceuticals Inc. (ID 435)

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 5
  • +

    ISS02 - Industry Supported Symposium: ALK and ROS1 in NSCLC: Optimising the Continuum of Care - Pfizer Oncology (ID 436)

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 8
  • +

    ISS03 - Industry Supported Symposium: Non-Small Cell Lung Cancer: The Programmed Death-Ligand 1 (PD-L1) Receptor as a Target for Monotherapy and in Combination – Merck-Pfizer Alliance (ID 437)

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 6